Medical Care
Global Radiotheranostic Market Research Report 2025
- May 05, 25
- ID: 226114
- Pages: 108
- Figures: 109
- Views: 36
The global market for Radiotheranostic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The field of radiotheranostic, which combines diagnostic and therapeutic applications of radiopharmaceuticals, is experiencing growth as it allows for more precise cancer diagnosis and treatment planning. Advances in targeted radiopharmaceuticals and imaging techniques are driving this trend.
This report aims to provide a comprehensive presentation of the global market for Radiotheranostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiotheranostic.
The Radiotheranostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radiotheranostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiotheranostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ITM Isotopen Technologien München AG
Advanced Accelerator Applications
Telix Pharmaceuticals
Theragnostics Ltd.
NuView Life Sciences
Jubilant Pharma Limited
Clarity Pharmaceuticals.
TransCode Therapeutics, Inc.
Curium SAS
GE Healthcare Inc.
Bayer AG
Lantheus Medical
Imaging, Inc.
Novartis AG
Spectrum Pharmaceuticals, Inc.
Ipsen S.A.
Actinium Pharmaceuticals, Inc. (ATNM)
Nordic Nanovector ASA
Y-mAbs Therapeutics, Inc.
Sofie Biosciences, Inc.
Terumo Corporation
Sirtex Medical Limited
Boston Scientific Corporation
Nihon Medi-Physics
Segment by Type
Nuclear Reactors
Cyclotrons
Segment by Application
Oncology
Non-Oncology
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiotheranostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The field of radiotheranostic, which combines diagnostic and therapeutic applications of radiopharmaceuticals, is experiencing growth as it allows for more precise cancer diagnosis and treatment planning. Advances in targeted radiopharmaceuticals and imaging techniques are driving this trend.
This report aims to provide a comprehensive presentation of the global market for Radiotheranostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiotheranostic.
The Radiotheranostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radiotheranostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiotheranostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ITM Isotopen Technologien München AG
Advanced Accelerator Applications
Telix Pharmaceuticals
Theragnostics Ltd.
NuView Life Sciences
Jubilant Pharma Limited
Clarity Pharmaceuticals.
TransCode Therapeutics, Inc.
Curium SAS
GE Healthcare Inc.
Bayer AG
Lantheus Medical
Imaging, Inc.
Novartis AG
Spectrum Pharmaceuticals, Inc.
Ipsen S.A.
Actinium Pharmaceuticals, Inc. (ATNM)
Nordic Nanovector ASA
Y-mAbs Therapeutics, Inc.
Sofie Biosciences, Inc.
Terumo Corporation
Sirtex Medical Limited
Boston Scientific Corporation
Nihon Medi-Physics
Segment by Type
Nuclear Reactors
Cyclotrons
Segment by Application
Oncology
Non-Oncology
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiotheranostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiotheranostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nuclear Reactors
1.2.3 Cyclotrons
1.3 Market by Application
1.3.1 Global Radiotheranostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Non-Oncology
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiotheranostic Market Perspective (2020-2031)
2.2 Global Radiotheranostic Growth Trends by Region
2.2.1 Global Radiotheranostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Radiotheranostic Historic Market Size by Region (2020-2025)
2.2.3 Radiotheranostic Forecasted Market Size by Region (2026-2031)
2.3 Radiotheranostic Market Dynamics
2.3.1 Radiotheranostic Industry Trends
2.3.2 Radiotheranostic Market Drivers
2.3.3 Radiotheranostic Market Challenges
2.3.4 Radiotheranostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiotheranostic Players by Revenue
3.1.1 Global Top Radiotheranostic Players by Revenue (2020-2025)
3.1.2 Global Radiotheranostic Revenue Market Share by Players (2020-2025)
3.2 Global Radiotheranostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Radiotheranostic Revenue
3.4 Global Radiotheranostic Market Concentration Ratio
3.4.1 Global Radiotheranostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiotheranostic Revenue in 2024
3.5 Global Key Players of Radiotheranostic Head office and Area Served
3.6 Global Key Players of Radiotheranostic, Product and Application
3.7 Global Key Players of Radiotheranostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiotheranostic Breakdown Data by Type
4.1 Global Radiotheranostic Historic Market Size by Type (2020-2025)
4.2 Global Radiotheranostic Forecasted Market Size by Type (2026-2031)
5 Radiotheranostic Breakdown Data by Application
5.1 Global Radiotheranostic Historic Market Size by Application (2020-2025)
5.2 Global Radiotheranostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Radiotheranostic Market Size (2020-2031)
6.2 North America Radiotheranostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Radiotheranostic Market Size by Country (2020-2025)
6.4 North America Radiotheranostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiotheranostic Market Size (2020-2031)
7.2 Europe Radiotheranostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Radiotheranostic Market Size by Country (2020-2025)
7.4 Europe Radiotheranostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiotheranostic Market Size (2020-2031)
8.2 Asia-Pacific Radiotheranostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Radiotheranostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Radiotheranostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radiotheranostic Market Size (2020-2031)
9.2 Latin America Radiotheranostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Radiotheranostic Market Size by Country (2020-2025)
9.4 Latin America Radiotheranostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiotheranostic Market Size (2020-2031)
10.2 Middle East & Africa Radiotheranostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Radiotheranostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Radiotheranostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ITM Isotopen Technologien München AG
11.1.1 ITM Isotopen Technologien München AG Company Details
11.1.2 ITM Isotopen Technologien München AG Business Overview
11.1.3 ITM Isotopen Technologien München AG Radiotheranostic Introduction
11.1.4 ITM Isotopen Technologien München AG Revenue in Radiotheranostic Business (2020-2025)
11.1.5 ITM Isotopen Technologien München AG Recent Development
11.2 Advanced Accelerator Applications
11.2.1 Advanced Accelerator Applications Company Details
11.2.2 Advanced Accelerator Applications Business Overview
11.2.3 Advanced Accelerator Applications Radiotheranostic Introduction
11.2.4 Advanced Accelerator Applications Revenue in Radiotheranostic Business (2020-2025)
11.2.5 Advanced Accelerator Applications Recent Development
11.3 Telix Pharmaceuticals
11.3.1 Telix Pharmaceuticals Company Details
11.3.2 Telix Pharmaceuticals Business Overview
11.3.3 Telix Pharmaceuticals Radiotheranostic Introduction
11.3.4 Telix Pharmaceuticals Revenue in Radiotheranostic Business (2020-2025)
11.3.5 Telix Pharmaceuticals Recent Development
11.4 Theragnostics Ltd.
11.4.1 Theragnostics Ltd. Company Details
11.4.2 Theragnostics Ltd. Business Overview
11.4.3 Theragnostics Ltd. Radiotheranostic Introduction
11.4.4 Theragnostics Ltd. Revenue in Radiotheranostic Business (2020-2025)
11.4.5 Theragnostics Ltd. Recent Development
11.5 NuView Life Sciences
11.5.1 NuView Life Sciences Company Details
11.5.2 NuView Life Sciences Business Overview
11.5.3 NuView Life Sciences Radiotheranostic Introduction
11.5.4 NuView Life Sciences Revenue in Radiotheranostic Business (2020-2025)
11.5.5 NuView Life Sciences Recent Development
11.6 Jubilant Pharma Limited
11.6.1 Jubilant Pharma Limited Company Details
11.6.2 Jubilant Pharma Limited Business Overview
11.6.3 Jubilant Pharma Limited Radiotheranostic Introduction
11.6.4 Jubilant Pharma Limited Revenue in Radiotheranostic Business (2020-2025)
11.6.5 Jubilant Pharma Limited Recent Development
11.7 Clarity Pharmaceuticals.
11.7.1 Clarity Pharmaceuticals. Company Details
11.7.2 Clarity Pharmaceuticals. Business Overview
11.7.3 Clarity Pharmaceuticals. Radiotheranostic Introduction
11.7.4 Clarity Pharmaceuticals. Revenue in Radiotheranostic Business (2020-2025)
11.7.5 Clarity Pharmaceuticals. Recent Development
11.8 TransCode Therapeutics, Inc.
11.8.1 TransCode Therapeutics, Inc. Company Details
11.8.2 TransCode Therapeutics, Inc. Business Overview
11.8.3 TransCode Therapeutics, Inc. Radiotheranostic Introduction
11.8.4 TransCode Therapeutics, Inc. Revenue in Radiotheranostic Business (2020-2025)
11.8.5 TransCode Therapeutics, Inc. Recent Development
11.9 Curium SAS
11.9.1 Curium SAS Company Details
11.9.2 Curium SAS Business Overview
11.9.3 Curium SAS Radiotheranostic Introduction
11.9.4 Curium SAS Revenue in Radiotheranostic Business (2020-2025)
11.9.5 Curium SAS Recent Development
11.10 GE Healthcare Inc.
11.10.1 GE Healthcare Inc. Company Details
11.10.2 GE Healthcare Inc. Business Overview
11.10.3 GE Healthcare Inc. Radiotheranostic Introduction
11.10.4 GE Healthcare Inc. Revenue in Radiotheranostic Business (2020-2025)
11.10.5 GE Healthcare Inc. Recent Development
11.11 Bayer AG
11.11.1 Bayer AG Company Details
11.11.2 Bayer AG Business Overview
11.11.3 Bayer AG Radiotheranostic Introduction
11.11.4 Bayer AG Revenue in Radiotheranostic Business (2020-2025)
11.11.5 Bayer AG Recent Development
11.12 Lantheus Medical
11.12.1 Lantheus Medical Company Details
11.12.2 Lantheus Medical Business Overview
11.12.3 Lantheus Medical Radiotheranostic Introduction
11.12.4 Lantheus Medical Revenue in Radiotheranostic Business (2020-2025)
11.12.5 Lantheus Medical Recent Development
11.13 Imaging, Inc.
11.13.1 Imaging, Inc. Company Details
11.13.2 Imaging, Inc. Business Overview
11.13.3 Imaging, Inc. Radiotheranostic Introduction
11.13.4 Imaging, Inc. Revenue in Radiotheranostic Business (2020-2025)
11.13.5 Imaging, Inc. Recent Development
11.14 Novartis AG
11.14.1 Novartis AG Company Details
11.14.2 Novartis AG Business Overview
11.14.3 Novartis AG Radiotheranostic Introduction
11.14.4 Novartis AG Revenue in Radiotheranostic Business (2020-2025)
11.14.5 Novartis AG Recent Development
11.15 Spectrum Pharmaceuticals, Inc.
11.15.1 Spectrum Pharmaceuticals, Inc. Company Details
11.15.2 Spectrum Pharmaceuticals, Inc. Business Overview
11.15.3 Spectrum Pharmaceuticals, Inc. Radiotheranostic Introduction
11.15.4 Spectrum Pharmaceuticals, Inc. Revenue in Radiotheranostic Business (2020-2025)
11.15.5 Spectrum Pharmaceuticals, Inc. Recent Development
11.16 Ipsen S.A.
11.16.1 Ipsen S.A. Company Details
11.16.2 Ipsen S.A. Business Overview
11.16.3 Ipsen S.A. Radiotheranostic Introduction
11.16.4 Ipsen S.A. Revenue in Radiotheranostic Business (2020-2025)
11.16.5 Ipsen S.A. Recent Development
11.17 Actinium Pharmaceuticals, Inc. (ATNM)
11.17.1 Actinium Pharmaceuticals, Inc. (ATNM) Company Details
11.17.2 Actinium Pharmaceuticals, Inc. (ATNM) Business Overview
11.17.3 Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Introduction
11.17.4 Actinium Pharmaceuticals, Inc. (ATNM) Revenue in Radiotheranostic Business (2020-2025)
11.17.5 Actinium Pharmaceuticals, Inc. (ATNM) Recent Development
11.18 Nordic Nanovector ASA
11.18.1 Nordic Nanovector ASA Company Details
11.18.2 Nordic Nanovector ASA Business Overview
11.18.3 Nordic Nanovector ASA Radiotheranostic Introduction
11.18.4 Nordic Nanovector ASA Revenue in Radiotheranostic Business (2020-2025)
11.18.5 Nordic Nanovector ASA Recent Development
11.19 Y-mAbs Therapeutics, Inc.
11.19.1 Y-mAbs Therapeutics, Inc. Company Details
11.19.2 Y-mAbs Therapeutics, Inc. Business Overview
11.19.3 Y-mAbs Therapeutics, Inc. Radiotheranostic Introduction
11.19.4 Y-mAbs Therapeutics, Inc. Revenue in Radiotheranostic Business (2020-2025)
11.19.5 Y-mAbs Therapeutics, Inc. Recent Development
11.20 Sofie Biosciences, Inc.
11.20.1 Sofie Biosciences, Inc. Company Details
11.20.2 Sofie Biosciences, Inc. Business Overview
11.20.3 Sofie Biosciences, Inc. Radiotheranostic Introduction
11.20.4 Sofie Biosciences, Inc. Revenue in Radiotheranostic Business (2020-2025)
11.20.5 Sofie Biosciences, Inc. Recent Development
11.21 Terumo Corporation
11.21.1 Terumo Corporation Company Details
11.21.2 Terumo Corporation Business Overview
11.21.3 Terumo Corporation Radiotheranostic Introduction
11.21.4 Terumo Corporation Revenue in Radiotheranostic Business (2020-2025)
11.21.5 Terumo Corporation Recent Development
11.22 Sirtex Medical Limited
11.22.1 Sirtex Medical Limited Company Details
11.22.2 Sirtex Medical Limited Business Overview
11.22.3 Sirtex Medical Limited Radiotheranostic Introduction
11.22.4 Sirtex Medical Limited Revenue in Radiotheranostic Business (2020-2025)
11.22.5 Sirtex Medical Limited Recent Development
11.23 Boston Scientific Corporation
11.23.1 Boston Scientific Corporation Company Details
11.23.2 Boston Scientific Corporation Business Overview
11.23.3 Boston Scientific Corporation Radiotheranostic Introduction
11.23.4 Boston Scientific Corporation Revenue in Radiotheranostic Business (2020-2025)
11.23.5 Boston Scientific Corporation Recent Development
11.24 Nihon Medi-Physics
11.24.1 Nihon Medi-Physics Company Details
11.24.2 Nihon Medi-Physics Business Overview
11.24.3 Nihon Medi-Physics Radiotheranostic Introduction
11.24.4 Nihon Medi-Physics Revenue in Radiotheranostic Business (2020-2025)
11.24.5 Nihon Medi-Physics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiotheranostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nuclear Reactors
1.2.3 Cyclotrons
1.3 Market by Application
1.3.1 Global Radiotheranostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Non-Oncology
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiotheranostic Market Perspective (2020-2031)
2.2 Global Radiotheranostic Growth Trends by Region
2.2.1 Global Radiotheranostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Radiotheranostic Historic Market Size by Region (2020-2025)
2.2.3 Radiotheranostic Forecasted Market Size by Region (2026-2031)
2.3 Radiotheranostic Market Dynamics
2.3.1 Radiotheranostic Industry Trends
2.3.2 Radiotheranostic Market Drivers
2.3.3 Radiotheranostic Market Challenges
2.3.4 Radiotheranostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiotheranostic Players by Revenue
3.1.1 Global Top Radiotheranostic Players by Revenue (2020-2025)
3.1.2 Global Radiotheranostic Revenue Market Share by Players (2020-2025)
3.2 Global Radiotheranostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Radiotheranostic Revenue
3.4 Global Radiotheranostic Market Concentration Ratio
3.4.1 Global Radiotheranostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiotheranostic Revenue in 2024
3.5 Global Key Players of Radiotheranostic Head office and Area Served
3.6 Global Key Players of Radiotheranostic, Product and Application
3.7 Global Key Players of Radiotheranostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiotheranostic Breakdown Data by Type
4.1 Global Radiotheranostic Historic Market Size by Type (2020-2025)
4.2 Global Radiotheranostic Forecasted Market Size by Type (2026-2031)
5 Radiotheranostic Breakdown Data by Application
5.1 Global Radiotheranostic Historic Market Size by Application (2020-2025)
5.2 Global Radiotheranostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Radiotheranostic Market Size (2020-2031)
6.2 North America Radiotheranostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Radiotheranostic Market Size by Country (2020-2025)
6.4 North America Radiotheranostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiotheranostic Market Size (2020-2031)
7.2 Europe Radiotheranostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Radiotheranostic Market Size by Country (2020-2025)
7.4 Europe Radiotheranostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiotheranostic Market Size (2020-2031)
8.2 Asia-Pacific Radiotheranostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Radiotheranostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Radiotheranostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radiotheranostic Market Size (2020-2031)
9.2 Latin America Radiotheranostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Radiotheranostic Market Size by Country (2020-2025)
9.4 Latin America Radiotheranostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiotheranostic Market Size (2020-2031)
10.2 Middle East & Africa Radiotheranostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Radiotheranostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Radiotheranostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ITM Isotopen Technologien München AG
11.1.1 ITM Isotopen Technologien München AG Company Details
11.1.2 ITM Isotopen Technologien München AG Business Overview
11.1.3 ITM Isotopen Technologien München AG Radiotheranostic Introduction
11.1.4 ITM Isotopen Technologien München AG Revenue in Radiotheranostic Business (2020-2025)
11.1.5 ITM Isotopen Technologien München AG Recent Development
11.2 Advanced Accelerator Applications
11.2.1 Advanced Accelerator Applications Company Details
11.2.2 Advanced Accelerator Applications Business Overview
11.2.3 Advanced Accelerator Applications Radiotheranostic Introduction
11.2.4 Advanced Accelerator Applications Revenue in Radiotheranostic Business (2020-2025)
11.2.5 Advanced Accelerator Applications Recent Development
11.3 Telix Pharmaceuticals
11.3.1 Telix Pharmaceuticals Company Details
11.3.2 Telix Pharmaceuticals Business Overview
11.3.3 Telix Pharmaceuticals Radiotheranostic Introduction
11.3.4 Telix Pharmaceuticals Revenue in Radiotheranostic Business (2020-2025)
11.3.5 Telix Pharmaceuticals Recent Development
11.4 Theragnostics Ltd.
11.4.1 Theragnostics Ltd. Company Details
11.4.2 Theragnostics Ltd. Business Overview
11.4.3 Theragnostics Ltd. Radiotheranostic Introduction
11.4.4 Theragnostics Ltd. Revenue in Radiotheranostic Business (2020-2025)
11.4.5 Theragnostics Ltd. Recent Development
11.5 NuView Life Sciences
11.5.1 NuView Life Sciences Company Details
11.5.2 NuView Life Sciences Business Overview
11.5.3 NuView Life Sciences Radiotheranostic Introduction
11.5.4 NuView Life Sciences Revenue in Radiotheranostic Business (2020-2025)
11.5.5 NuView Life Sciences Recent Development
11.6 Jubilant Pharma Limited
11.6.1 Jubilant Pharma Limited Company Details
11.6.2 Jubilant Pharma Limited Business Overview
11.6.3 Jubilant Pharma Limited Radiotheranostic Introduction
11.6.4 Jubilant Pharma Limited Revenue in Radiotheranostic Business (2020-2025)
11.6.5 Jubilant Pharma Limited Recent Development
11.7 Clarity Pharmaceuticals.
11.7.1 Clarity Pharmaceuticals. Company Details
11.7.2 Clarity Pharmaceuticals. Business Overview
11.7.3 Clarity Pharmaceuticals. Radiotheranostic Introduction
11.7.4 Clarity Pharmaceuticals. Revenue in Radiotheranostic Business (2020-2025)
11.7.5 Clarity Pharmaceuticals. Recent Development
11.8 TransCode Therapeutics, Inc.
11.8.1 TransCode Therapeutics, Inc. Company Details
11.8.2 TransCode Therapeutics, Inc. Business Overview
11.8.3 TransCode Therapeutics, Inc. Radiotheranostic Introduction
11.8.4 TransCode Therapeutics, Inc. Revenue in Radiotheranostic Business (2020-2025)
11.8.5 TransCode Therapeutics, Inc. Recent Development
11.9 Curium SAS
11.9.1 Curium SAS Company Details
11.9.2 Curium SAS Business Overview
11.9.3 Curium SAS Radiotheranostic Introduction
11.9.4 Curium SAS Revenue in Radiotheranostic Business (2020-2025)
11.9.5 Curium SAS Recent Development
11.10 GE Healthcare Inc.
11.10.1 GE Healthcare Inc. Company Details
11.10.2 GE Healthcare Inc. Business Overview
11.10.3 GE Healthcare Inc. Radiotheranostic Introduction
11.10.4 GE Healthcare Inc. Revenue in Radiotheranostic Business (2020-2025)
11.10.5 GE Healthcare Inc. Recent Development
11.11 Bayer AG
11.11.1 Bayer AG Company Details
11.11.2 Bayer AG Business Overview
11.11.3 Bayer AG Radiotheranostic Introduction
11.11.4 Bayer AG Revenue in Radiotheranostic Business (2020-2025)
11.11.5 Bayer AG Recent Development
11.12 Lantheus Medical
11.12.1 Lantheus Medical Company Details
11.12.2 Lantheus Medical Business Overview
11.12.3 Lantheus Medical Radiotheranostic Introduction
11.12.4 Lantheus Medical Revenue in Radiotheranostic Business (2020-2025)
11.12.5 Lantheus Medical Recent Development
11.13 Imaging, Inc.
11.13.1 Imaging, Inc. Company Details
11.13.2 Imaging, Inc. Business Overview
11.13.3 Imaging, Inc. Radiotheranostic Introduction
11.13.4 Imaging, Inc. Revenue in Radiotheranostic Business (2020-2025)
11.13.5 Imaging, Inc. Recent Development
11.14 Novartis AG
11.14.1 Novartis AG Company Details
11.14.2 Novartis AG Business Overview
11.14.3 Novartis AG Radiotheranostic Introduction
11.14.4 Novartis AG Revenue in Radiotheranostic Business (2020-2025)
11.14.5 Novartis AG Recent Development
11.15 Spectrum Pharmaceuticals, Inc.
11.15.1 Spectrum Pharmaceuticals, Inc. Company Details
11.15.2 Spectrum Pharmaceuticals, Inc. Business Overview
11.15.3 Spectrum Pharmaceuticals, Inc. Radiotheranostic Introduction
11.15.4 Spectrum Pharmaceuticals, Inc. Revenue in Radiotheranostic Business (2020-2025)
11.15.5 Spectrum Pharmaceuticals, Inc. Recent Development
11.16 Ipsen S.A.
11.16.1 Ipsen S.A. Company Details
11.16.2 Ipsen S.A. Business Overview
11.16.3 Ipsen S.A. Radiotheranostic Introduction
11.16.4 Ipsen S.A. Revenue in Radiotheranostic Business (2020-2025)
11.16.5 Ipsen S.A. Recent Development
11.17 Actinium Pharmaceuticals, Inc. (ATNM)
11.17.1 Actinium Pharmaceuticals, Inc. (ATNM) Company Details
11.17.2 Actinium Pharmaceuticals, Inc. (ATNM) Business Overview
11.17.3 Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Introduction
11.17.4 Actinium Pharmaceuticals, Inc. (ATNM) Revenue in Radiotheranostic Business (2020-2025)
11.17.5 Actinium Pharmaceuticals, Inc. (ATNM) Recent Development
11.18 Nordic Nanovector ASA
11.18.1 Nordic Nanovector ASA Company Details
11.18.2 Nordic Nanovector ASA Business Overview
11.18.3 Nordic Nanovector ASA Radiotheranostic Introduction
11.18.4 Nordic Nanovector ASA Revenue in Radiotheranostic Business (2020-2025)
11.18.5 Nordic Nanovector ASA Recent Development
11.19 Y-mAbs Therapeutics, Inc.
11.19.1 Y-mAbs Therapeutics, Inc. Company Details
11.19.2 Y-mAbs Therapeutics, Inc. Business Overview
11.19.3 Y-mAbs Therapeutics, Inc. Radiotheranostic Introduction
11.19.4 Y-mAbs Therapeutics, Inc. Revenue in Radiotheranostic Business (2020-2025)
11.19.5 Y-mAbs Therapeutics, Inc. Recent Development
11.20 Sofie Biosciences, Inc.
11.20.1 Sofie Biosciences, Inc. Company Details
11.20.2 Sofie Biosciences, Inc. Business Overview
11.20.3 Sofie Biosciences, Inc. Radiotheranostic Introduction
11.20.4 Sofie Biosciences, Inc. Revenue in Radiotheranostic Business (2020-2025)
11.20.5 Sofie Biosciences, Inc. Recent Development
11.21 Terumo Corporation
11.21.1 Terumo Corporation Company Details
11.21.2 Terumo Corporation Business Overview
11.21.3 Terumo Corporation Radiotheranostic Introduction
11.21.4 Terumo Corporation Revenue in Radiotheranostic Business (2020-2025)
11.21.5 Terumo Corporation Recent Development
11.22 Sirtex Medical Limited
11.22.1 Sirtex Medical Limited Company Details
11.22.2 Sirtex Medical Limited Business Overview
11.22.3 Sirtex Medical Limited Radiotheranostic Introduction
11.22.4 Sirtex Medical Limited Revenue in Radiotheranostic Business (2020-2025)
11.22.5 Sirtex Medical Limited Recent Development
11.23 Boston Scientific Corporation
11.23.1 Boston Scientific Corporation Company Details
11.23.2 Boston Scientific Corporation Business Overview
11.23.3 Boston Scientific Corporation Radiotheranostic Introduction
11.23.4 Boston Scientific Corporation Revenue in Radiotheranostic Business (2020-2025)
11.23.5 Boston Scientific Corporation Recent Development
11.24 Nihon Medi-Physics
11.24.1 Nihon Medi-Physics Company Details
11.24.2 Nihon Medi-Physics Business Overview
11.24.3 Nihon Medi-Physics Radiotheranostic Introduction
11.24.4 Nihon Medi-Physics Revenue in Radiotheranostic Business (2020-2025)
11.24.5 Nihon Medi-Physics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Radiotheranostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Nuclear Reactors
Table 3. Key Players of Cyclotrons
Table 4. Global Radiotheranostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Radiotheranostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Radiotheranostic Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Radiotheranostic Market Share by Region (2020-2025)
Table 8. Global Radiotheranostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Radiotheranostic Market Share by Region (2026-2031)
Table 10. Radiotheranostic Market Trends
Table 11. Radiotheranostic Market Drivers
Table 12. Radiotheranostic Market Challenges
Table 13. Radiotheranostic Market Restraints
Table 14. Global Radiotheranostic Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Radiotheranostic Market Share by Players (2020-2025)
Table 16. Global Top Radiotheranostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiotheranostic as of 2024)
Table 17. Ranking of Global Top Radiotheranostic Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Radiotheranostic Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Radiotheranostic, Headquarters and Area Served
Table 20. Global Key Players of Radiotheranostic, Product and Application
Table 21. Global Key Players of Radiotheranostic, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Radiotheranostic Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Radiotheranostic Revenue Market Share by Type (2020-2025)
Table 25. Global Radiotheranostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Radiotheranostic Revenue Market Share by Type (2026-2031)
Table 27. Global Radiotheranostic Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Radiotheranostic Revenue Market Share by Application (2020-2025)
Table 29. Global Radiotheranostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Radiotheranostic Revenue Market Share by Application (2026-2031)
Table 31. North America Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Radiotheranostic Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Radiotheranostic Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Radiotheranostic Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Radiotheranostic Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Radiotheranostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Radiotheranostic Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Radiotheranostic Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Radiotheranostic Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Radiotheranostic Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Radiotheranostic Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Radiotheranostic Market Size by Country (2026-2031) & (US$ Million)
Table 46. ITM Isotopen Technologien München AG Company Details
Table 47. ITM Isotopen Technologien München AG Business Overview
Table 48. ITM Isotopen Technologien München AG Radiotheranostic Product
Table 49. ITM Isotopen Technologien München AG Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 50. ITM Isotopen Technologien München AG Recent Development
Table 51. Advanced Accelerator Applications Company Details
Table 52. Advanced Accelerator Applications Business Overview
Table 53. Advanced Accelerator Applications Radiotheranostic Product
Table 54. Advanced Accelerator Applications Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 55. Advanced Accelerator Applications Recent Development
Table 56. Telix Pharmaceuticals Company Details
Table 57. Telix Pharmaceuticals Business Overview
Table 58. Telix Pharmaceuticals Radiotheranostic Product
Table 59. Telix Pharmaceuticals Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 60. Telix Pharmaceuticals Recent Development
Table 61. Theragnostics Ltd. Company Details
Table 62. Theragnostics Ltd. Business Overview
Table 63. Theragnostics Ltd. Radiotheranostic Product
Table 64. Theragnostics Ltd. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 65. Theragnostics Ltd. Recent Development
Table 66. NuView Life Sciences Company Details
Table 67. NuView Life Sciences Business Overview
Table 68. NuView Life Sciences Radiotheranostic Product
Table 69. NuView Life Sciences Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 70. NuView Life Sciences Recent Development
Table 71. Jubilant Pharma Limited Company Details
Table 72. Jubilant Pharma Limited Business Overview
Table 73. Jubilant Pharma Limited Radiotheranostic Product
Table 74. Jubilant Pharma Limited Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 75. Jubilant Pharma Limited Recent Development
Table 76. Clarity Pharmaceuticals. Company Details
Table 77. Clarity Pharmaceuticals. Business Overview
Table 78. Clarity Pharmaceuticals. Radiotheranostic Product
Table 79. Clarity Pharmaceuticals. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 80. Clarity Pharmaceuticals. Recent Development
Table 81. TransCode Therapeutics, Inc. Company Details
Table 82. TransCode Therapeutics, Inc. Business Overview
Table 83. TransCode Therapeutics, Inc. Radiotheranostic Product
Table 84. TransCode Therapeutics, Inc. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 85. TransCode Therapeutics, Inc. Recent Development
Table 86. Curium SAS Company Details
Table 87. Curium SAS Business Overview
Table 88. Curium SAS Radiotheranostic Product
Table 89. Curium SAS Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 90. Curium SAS Recent Development
Table 91. GE Healthcare Inc. Company Details
Table 92. GE Healthcare Inc. Business Overview
Table 93. GE Healthcare Inc. Radiotheranostic Product
Table 94. GE Healthcare Inc. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 95. GE Healthcare Inc. Recent Development
Table 96. Bayer AG Company Details
Table 97. Bayer AG Business Overview
Table 98. Bayer AG Radiotheranostic Product
Table 99. Bayer AG Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 100. Bayer AG Recent Development
Table 101. Lantheus Medical Company Details
Table 102. Lantheus Medical Business Overview
Table 103. Lantheus Medical Radiotheranostic Product
Table 104. Lantheus Medical Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 105. Lantheus Medical Recent Development
Table 106. Imaging, Inc. Company Details
Table 107. Imaging, Inc. Business Overview
Table 108. Imaging, Inc. Radiotheranostic Product
Table 109. Imaging, Inc. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 110. Imaging, Inc. Recent Development
Table 111. Novartis AG Company Details
Table 112. Novartis AG Business Overview
Table 113. Novartis AG Radiotheranostic Product
Table 114. Novartis AG Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 115. Novartis AG Recent Development
Table 116. Spectrum Pharmaceuticals, Inc. Company Details
Table 117. Spectrum Pharmaceuticals, Inc. Business Overview
Table 118. Spectrum Pharmaceuticals, Inc. Radiotheranostic Product
Table 119. Spectrum Pharmaceuticals, Inc. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 120. Spectrum Pharmaceuticals, Inc. Recent Development
Table 121. Ipsen S.A. Company Details
Table 122. Ipsen S.A. Business Overview
Table 123. Ipsen S.A. Radiotheranostic Product
Table 124. Ipsen S.A. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 125. Ipsen S.A. Recent Development
Table 126. Actinium Pharmaceuticals, Inc. (ATNM) Company Details
Table 127. Actinium Pharmaceuticals, Inc. (ATNM) Business Overview
Table 128. Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Product
Table 129. Actinium Pharmaceuticals, Inc. (ATNM) Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 130. Actinium Pharmaceuticals, Inc. (ATNM) Recent Development
Table 131. Nordic Nanovector ASA Company Details
Table 132. Nordic Nanovector ASA Business Overview
Table 133. Nordic Nanovector ASA Radiotheranostic Product
Table 134. Nordic Nanovector ASA Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 135. Nordic Nanovector ASA Recent Development
Table 136. Y-mAbs Therapeutics, Inc. Company Details
Table 137. Y-mAbs Therapeutics, Inc. Business Overview
Table 138. Y-mAbs Therapeutics, Inc. Radiotheranostic Product
Table 139. Y-mAbs Therapeutics, Inc. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 140. Y-mAbs Therapeutics, Inc. Recent Development
Table 141. Sofie Biosciences, Inc. Company Details
Table 142. Sofie Biosciences, Inc. Business Overview
Table 143. Sofie Biosciences, Inc. Radiotheranostic Product
Table 144. Sofie Biosciences, Inc. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 145. Sofie Biosciences, Inc. Recent Development
Table 146. Terumo Corporation Company Details
Table 147. Terumo Corporation Business Overview
Table 148. Terumo Corporation Radiotheranostic Product
Table 149. Terumo Corporation Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 150. Terumo Corporation Recent Development
Table 151. Sirtex Medical Limited Company Details
Table 152. Sirtex Medical Limited Business Overview
Table 153. Sirtex Medical Limited Radiotheranostic Product
Table 154. Sirtex Medical Limited Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 155. Sirtex Medical Limited Recent Development
Table 156. Boston Scientific Corporation Company Details
Table 157. Boston Scientific Corporation Business Overview
Table 158. Boston Scientific Corporation Radiotheranostic Product
Table 159. Boston Scientific Corporation Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 160. Boston Scientific Corporation Recent Development
Table 161. Nihon Medi-Physics Company Details
Table 162. Nihon Medi-Physics Business Overview
Table 163. Nihon Medi-Physics Radiotheranostic Product
Table 164. Nihon Medi-Physics Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 165. Nihon Medi-Physics Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
Table 169. Authors List of This Report
List of Figures
Figure 1. Radiotheranostic Picture
Figure 2. Global Radiotheranostic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Radiotheranostic Market Share by Type: 2024 VS 2031
Figure 4. Nuclear Reactors Features
Figure 5. Cyclotrons Features
Figure 6. Global Radiotheranostic Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Radiotheranostic Market Share by Application: 2024 VS 2031
Figure 8. Oncology Case Studies
Figure 9. Non-Oncology Case Studies
Figure 10. Radiotheranostic Report Years Considered
Figure 11. Global Radiotheranostic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Radiotheranostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Radiotheranostic Market Share by Region: 2024 VS 2031
Figure 14. Global Radiotheranostic Market Share by Players in 2024
Figure 15. Global Top Radiotheranostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiotheranostic as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Radiotheranostic Revenue in 2024
Figure 17. North America Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Radiotheranostic Market Share by Country (2020-2031)
Figure 19. United States Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Radiotheranostic Market Share by Country (2020-2031)
Figure 23. Germany Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Radiotheranostic Market Share by Region (2020-2031)
Figure 31. China Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Radiotheranostic Market Share by Country (2020-2031)
Figure 39. Mexico Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Radiotheranostic Market Share by Country (2020-2031)
Figure 43. Turkey Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. ITM Isotopen Technologien München AG Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 47. Advanced Accelerator Applications Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 48. Telix Pharmaceuticals Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 49. Theragnostics Ltd. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 50. NuView Life Sciences Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 51. Jubilant Pharma Limited Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 52. Clarity Pharmaceuticals. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 53. TransCode Therapeutics, Inc. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 54. Curium SAS Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 55. GE Healthcare Inc. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 56. Bayer AG Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 57. Lantheus Medical Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 58. Imaging, Inc. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 59. Novartis AG Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 60. Spectrum Pharmaceuticals, Inc. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 61. Ipsen S.A. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 62. Actinium Pharmaceuticals, Inc. (ATNM) Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 63. Nordic Nanovector ASA Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 64. Y-mAbs Therapeutics, Inc. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 65. Sofie Biosciences, Inc. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 66. Terumo Corporation Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 67. Sirtex Medical Limited Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 68. Boston Scientific Corporation Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 69. Nihon Medi-Physics Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Table 1. Global Radiotheranostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Nuclear Reactors
Table 3. Key Players of Cyclotrons
Table 4. Global Radiotheranostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Radiotheranostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Radiotheranostic Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Radiotheranostic Market Share by Region (2020-2025)
Table 8. Global Radiotheranostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Radiotheranostic Market Share by Region (2026-2031)
Table 10. Radiotheranostic Market Trends
Table 11. Radiotheranostic Market Drivers
Table 12. Radiotheranostic Market Challenges
Table 13. Radiotheranostic Market Restraints
Table 14. Global Radiotheranostic Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Radiotheranostic Market Share by Players (2020-2025)
Table 16. Global Top Radiotheranostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiotheranostic as of 2024)
Table 17. Ranking of Global Top Radiotheranostic Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Radiotheranostic Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Radiotheranostic, Headquarters and Area Served
Table 20. Global Key Players of Radiotheranostic, Product and Application
Table 21. Global Key Players of Radiotheranostic, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Radiotheranostic Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Radiotheranostic Revenue Market Share by Type (2020-2025)
Table 25. Global Radiotheranostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Radiotheranostic Revenue Market Share by Type (2026-2031)
Table 27. Global Radiotheranostic Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Radiotheranostic Revenue Market Share by Application (2020-2025)
Table 29. Global Radiotheranostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Radiotheranostic Revenue Market Share by Application (2026-2031)
Table 31. North America Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Radiotheranostic Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Radiotheranostic Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Radiotheranostic Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Radiotheranostic Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Radiotheranostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Radiotheranostic Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Radiotheranostic Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Radiotheranostic Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Radiotheranostic Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Radiotheranostic Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Radiotheranostic Market Size by Country (2026-2031) & (US$ Million)
Table 46. ITM Isotopen Technologien München AG Company Details
Table 47. ITM Isotopen Technologien München AG Business Overview
Table 48. ITM Isotopen Technologien München AG Radiotheranostic Product
Table 49. ITM Isotopen Technologien München AG Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 50. ITM Isotopen Technologien München AG Recent Development
Table 51. Advanced Accelerator Applications Company Details
Table 52. Advanced Accelerator Applications Business Overview
Table 53. Advanced Accelerator Applications Radiotheranostic Product
Table 54. Advanced Accelerator Applications Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 55. Advanced Accelerator Applications Recent Development
Table 56. Telix Pharmaceuticals Company Details
Table 57. Telix Pharmaceuticals Business Overview
Table 58. Telix Pharmaceuticals Radiotheranostic Product
Table 59. Telix Pharmaceuticals Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 60. Telix Pharmaceuticals Recent Development
Table 61. Theragnostics Ltd. Company Details
Table 62. Theragnostics Ltd. Business Overview
Table 63. Theragnostics Ltd. Radiotheranostic Product
Table 64. Theragnostics Ltd. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 65. Theragnostics Ltd. Recent Development
Table 66. NuView Life Sciences Company Details
Table 67. NuView Life Sciences Business Overview
Table 68. NuView Life Sciences Radiotheranostic Product
Table 69. NuView Life Sciences Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 70. NuView Life Sciences Recent Development
Table 71. Jubilant Pharma Limited Company Details
Table 72. Jubilant Pharma Limited Business Overview
Table 73. Jubilant Pharma Limited Radiotheranostic Product
Table 74. Jubilant Pharma Limited Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 75. Jubilant Pharma Limited Recent Development
Table 76. Clarity Pharmaceuticals. Company Details
Table 77. Clarity Pharmaceuticals. Business Overview
Table 78. Clarity Pharmaceuticals. Radiotheranostic Product
Table 79. Clarity Pharmaceuticals. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 80. Clarity Pharmaceuticals. Recent Development
Table 81. TransCode Therapeutics, Inc. Company Details
Table 82. TransCode Therapeutics, Inc. Business Overview
Table 83. TransCode Therapeutics, Inc. Radiotheranostic Product
Table 84. TransCode Therapeutics, Inc. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 85. TransCode Therapeutics, Inc. Recent Development
Table 86. Curium SAS Company Details
Table 87. Curium SAS Business Overview
Table 88. Curium SAS Radiotheranostic Product
Table 89. Curium SAS Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 90. Curium SAS Recent Development
Table 91. GE Healthcare Inc. Company Details
Table 92. GE Healthcare Inc. Business Overview
Table 93. GE Healthcare Inc. Radiotheranostic Product
Table 94. GE Healthcare Inc. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 95. GE Healthcare Inc. Recent Development
Table 96. Bayer AG Company Details
Table 97. Bayer AG Business Overview
Table 98. Bayer AG Radiotheranostic Product
Table 99. Bayer AG Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 100. Bayer AG Recent Development
Table 101. Lantheus Medical Company Details
Table 102. Lantheus Medical Business Overview
Table 103. Lantheus Medical Radiotheranostic Product
Table 104. Lantheus Medical Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 105. Lantheus Medical Recent Development
Table 106. Imaging, Inc. Company Details
Table 107. Imaging, Inc. Business Overview
Table 108. Imaging, Inc. Radiotheranostic Product
Table 109. Imaging, Inc. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 110. Imaging, Inc. Recent Development
Table 111. Novartis AG Company Details
Table 112. Novartis AG Business Overview
Table 113. Novartis AG Radiotheranostic Product
Table 114. Novartis AG Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 115. Novartis AG Recent Development
Table 116. Spectrum Pharmaceuticals, Inc. Company Details
Table 117. Spectrum Pharmaceuticals, Inc. Business Overview
Table 118. Spectrum Pharmaceuticals, Inc. Radiotheranostic Product
Table 119. Spectrum Pharmaceuticals, Inc. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 120. Spectrum Pharmaceuticals, Inc. Recent Development
Table 121. Ipsen S.A. Company Details
Table 122. Ipsen S.A. Business Overview
Table 123. Ipsen S.A. Radiotheranostic Product
Table 124. Ipsen S.A. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 125. Ipsen S.A. Recent Development
Table 126. Actinium Pharmaceuticals, Inc. (ATNM) Company Details
Table 127. Actinium Pharmaceuticals, Inc. (ATNM) Business Overview
Table 128. Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Product
Table 129. Actinium Pharmaceuticals, Inc. (ATNM) Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 130. Actinium Pharmaceuticals, Inc. (ATNM) Recent Development
Table 131. Nordic Nanovector ASA Company Details
Table 132. Nordic Nanovector ASA Business Overview
Table 133. Nordic Nanovector ASA Radiotheranostic Product
Table 134. Nordic Nanovector ASA Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 135. Nordic Nanovector ASA Recent Development
Table 136. Y-mAbs Therapeutics, Inc. Company Details
Table 137. Y-mAbs Therapeutics, Inc. Business Overview
Table 138. Y-mAbs Therapeutics, Inc. Radiotheranostic Product
Table 139. Y-mAbs Therapeutics, Inc. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 140. Y-mAbs Therapeutics, Inc. Recent Development
Table 141. Sofie Biosciences, Inc. Company Details
Table 142. Sofie Biosciences, Inc. Business Overview
Table 143. Sofie Biosciences, Inc. Radiotheranostic Product
Table 144. Sofie Biosciences, Inc. Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 145. Sofie Biosciences, Inc. Recent Development
Table 146. Terumo Corporation Company Details
Table 147. Terumo Corporation Business Overview
Table 148. Terumo Corporation Radiotheranostic Product
Table 149. Terumo Corporation Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 150. Terumo Corporation Recent Development
Table 151. Sirtex Medical Limited Company Details
Table 152. Sirtex Medical Limited Business Overview
Table 153. Sirtex Medical Limited Radiotheranostic Product
Table 154. Sirtex Medical Limited Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 155. Sirtex Medical Limited Recent Development
Table 156. Boston Scientific Corporation Company Details
Table 157. Boston Scientific Corporation Business Overview
Table 158. Boston Scientific Corporation Radiotheranostic Product
Table 159. Boston Scientific Corporation Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 160. Boston Scientific Corporation Recent Development
Table 161. Nihon Medi-Physics Company Details
Table 162. Nihon Medi-Physics Business Overview
Table 163. Nihon Medi-Physics Radiotheranostic Product
Table 164. Nihon Medi-Physics Revenue in Radiotheranostic Business (2020-2025) & (US$ Million)
Table 165. Nihon Medi-Physics Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
Table 169. Authors List of This Report
List of Figures
Figure 1. Radiotheranostic Picture
Figure 2. Global Radiotheranostic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Radiotheranostic Market Share by Type: 2024 VS 2031
Figure 4. Nuclear Reactors Features
Figure 5. Cyclotrons Features
Figure 6. Global Radiotheranostic Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Radiotheranostic Market Share by Application: 2024 VS 2031
Figure 8. Oncology Case Studies
Figure 9. Non-Oncology Case Studies
Figure 10. Radiotheranostic Report Years Considered
Figure 11. Global Radiotheranostic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Radiotheranostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Radiotheranostic Market Share by Region: 2024 VS 2031
Figure 14. Global Radiotheranostic Market Share by Players in 2024
Figure 15. Global Top Radiotheranostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiotheranostic as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Radiotheranostic Revenue in 2024
Figure 17. North America Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Radiotheranostic Market Share by Country (2020-2031)
Figure 19. United States Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Radiotheranostic Market Share by Country (2020-2031)
Figure 23. Germany Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Radiotheranostic Market Share by Region (2020-2031)
Figure 31. China Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Radiotheranostic Market Share by Country (2020-2031)
Figure 39. Mexico Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Radiotheranostic Market Share by Country (2020-2031)
Figure 43. Turkey Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Radiotheranostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. ITM Isotopen Technologien München AG Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 47. Advanced Accelerator Applications Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 48. Telix Pharmaceuticals Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 49. Theragnostics Ltd. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 50. NuView Life Sciences Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 51. Jubilant Pharma Limited Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 52. Clarity Pharmaceuticals. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 53. TransCode Therapeutics, Inc. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 54. Curium SAS Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 55. GE Healthcare Inc. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 56. Bayer AG Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 57. Lantheus Medical Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 58. Imaging, Inc. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 59. Novartis AG Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 60. Spectrum Pharmaceuticals, Inc. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 61. Ipsen S.A. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 62. Actinium Pharmaceuticals, Inc. (ATNM) Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 63. Nordic Nanovector ASA Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 64. Y-mAbs Therapeutics, Inc. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 65. Sofie Biosciences, Inc. Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 66. Terumo Corporation Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 67. Sirtex Medical Limited Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 68. Boston Scientific Corporation Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 69. Nihon Medi-Physics Revenue Growth Rate in Radiotheranostic Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232